Anavex Life Sciences Corp (AVXL)

[Boopka]

Per the presentation the cost for dementia is going to double from $1 trillion WW to $2 trillion by 2030. That means that one of the largest unmet medical needs has a compound annual growth of approximately 10% on top of the already huge investment opportunity. If the data is every bit as good as we think it will be Missling has the leverage to land a very lucrative deal for Anavex and us shareholders. I wish I were a fly on the wall over there these days.